Michael E. Farkouh, MD, MSc

Articles by Michael E. Farkouh, MD, MSc

LDL Cholesterol Response and Statin Adherence Among High-Risk Patients Initiating Treatment

BySuma Vupputuri, PhD, MPH,Peter J. Joski, MS,Ryan Kilpatrick, PhD,J. Michael Woolley, PhD,Brandi E. Robinson, MPH,Michael E. Farkouh, MD, MSc,Huifeng Yun, PhD,Monika M. Safford, MD,Paul Muntner, PhD

March 4th 2016

Nonadherence is common among high-risk patients initiating statins and is associated with suboptimal low-density lipoprotein cholesterol (LDL-C) reduction. LDL-C should be monitored to identify suboptimal response and medication nonadherence.

Latest Updated Articles

LDL Cholesterol Response and Statin Adherence Among High-Risk Patients Initiating Treatment
Published: March 4th 2016 | Updated:

Michael E. Farkouh, MD, MSc

Articles by Michael E. Farkouh, MD, MSc

LDL Cholesterol Response and Statin Adherence Among High-Risk Patients Initiating Treatment

Latest Updated Articles

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

5 Things to Know About the Oral GLP-1 Era

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention